Literature DB >> 5653685

The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects.

E Dowdle, P Mustard, N Spong, L Eales.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5653685

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  10 in total

Review 1.  Folate-Dependent Purine Nucleotide Biosynthesis in Humans.

Authors:  Joseph E Baggott; Tsunenobu Tamura
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

Review 2.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

Review 3.  [Biochemical pathogenesis of acute intermittent porphyria].

Authors:  L Heilmeyer; R Clotten
Journal:  Klin Wochenschr       Date:  1969-01-15

4.  [Erythrocyte delta-aminolevulinic acid metabolism as modified by heme metabolites].

Authors:  D Schmidt; W Pape; W Stich
Journal:  Blut       Date:  1973-05

5.  Hepatic porphyrias.

Authors: 
Journal:  Br Med J       Date:  1971-05-01

6.  Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.

Authors:  Annika Johansson; Christer Möller; Jens Fogh; Pauline Harper
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

7.  Biosynthesis of 5-aminolevulinic acid and heme from 4,5-dioxovalerate in the rat.

Authors:  K A Morton; J P Kushner; J G Straka; B F Burnham
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

8.  Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.

Authors:  L J Strand; B F Felsher; A G Redeker; H S Marver
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

9.  Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man.

Authors:  E A Jones; R Shrager; J R Bloomer; P D Berk; R B Howe; N I Berlin
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

10.  Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

Authors:  A C Laiwah; A Goldberg; M R Moore
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.